Evidence map›Paper›PMID 26978517›Full record

ArticlePloS one2016

Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study.

Naoyoshi Nagata, Ryota Niikura, Atsuo Yamada, Toshiyuki Sakurai, Takuro Shimbo, Yuka Kobayashi, Makoto Okamoto, Yuzo Mitsuno, Keiji Ogura, Yoshihiro Hirata and 4 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Naoyoshi NagataDepartments of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
Ryota NiikuraDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Atsuo YamadaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Toshiyuki SakuraiDepartments of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
Takuro ShimboOhta Nishinouchi Hospital, Fukushima, Japan.
Yuka KobayashiDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Makoto OkamotoDepartment of Gastroenterology, JR Tokyo General Hospital, Tokyo, Japan.
Yuzo MitsunoDepartment of Gastroenterology, Japanese Red Cross Medical Center, Tokyo, Japan.
Keiji OguraDepartment of Gastroenterology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Yoshihiro HirataDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kazuma FujimotoDepartment of Internal Medicine and Gastrointestinal Endoscopy, Saga Medical School, Saga, Japan.
Junichi AkiyamaDepartments of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
Naomi UemuraDepartment of Gastroenterology, Tokyo Metropolitan Police Hospital, Chiba, Japan.
Kazuhiko KoikeDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPNational Center for Global Health and Medicine · JPTokyo Metropolitan Police Hospital · JPJapanese Red Cross Medical Center · JPJR Tokyo General Hospital · JPOhta Nishinouchi Hospital · JPSaga Medical School Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMiddle gastrointestinal bleeding (MGIB) risk has not been fully investigated due to its extremely rare occurrence and the need for multiple endoscopies to exclude upper and lower gastrointestinal bleeding. This study investigated whether MGIB is associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs), low-dose aspirin (LDA), thienopyridines, anticoagulants, and proton-pump inhibitors (PPIs), and whether PPI use affects the interactions between MGIB and antithrombotic drugs.

methodsIn this multicenter, hospital-based, case-control study, 400 patients underwent upper and lower endoscopy, 80 had acute overt MGIB and 320 had no bleeding and were matched for age and sex as controls (1:4). MGIB was additionally evaluated by capsule and/or double-balloon endoscopy, after excluding upper and lower GI bleeding. Adjusted odds ratios (AOR) for MGIB risk were calculated using conditional logistic regression. To estimate the propensity score, we employed a logistic regression model for PPI use.

resultsIn patients with MGIB, mean hemoglobin level was 9.4 g/dL, and 28 patients (35%) received blood transfusions. Factors significantly associated with MGIB were chronic kidney disease (p<0.001), liver cirrhosis (p = 0.034), NSAIDs (p<0.001), thienopyridines (p<0.001), anticoagulants (p = 0.002), and PPIs (p<0.001). After adjusting for these factors, NSAIDs (AOR, 2.5; p = 0.018), thienopyridines (AOR, 3.2; p = 0.015), anticoagulants (AOR, 4.3; p = 0.028), and PPIs (AOR; 2.0; p = 0.021) were independently associated with MGIB. After adjusting for propensity score, the use of PPIs remained an independent risk factors for MGIB (AOR, 1.94; p = 0.034). No significant interactions were observed between PPIs and NSAIDs (AOR, 0.7; p = 0.637), LDA (AOR, 0.3; p = 0.112), thienopyridine (AOR, 0.7, p = 0.671), or anticoagulants (AOR, 0.5; p = 0.545).

conclusionsOne-third of patients with acute small intestinal bleeding required blood transfusion. NSAIDs, thienopyridines, anticoagulants, and PPIs increased the risk of acute small intestinal bleeding. However, there were no significant interactions found between antithrombotic drugs and PPI use for bleeding risk.

Indexed as

AdultAgedAged, 80 and overAnticoagulantsAnti-Inflammatory Agents, Non-SteroidalAspirinCase-Control StudiesFemaleGastrointestinal HemorrhageHumansMaleMiddle AgedPlatelet Aggregation InhibitorsProton Pump InhibitorsRetrospective StudiesRisk FactorsAnticoagulantsAnti-Inflammatory Agents, Non-SteroidalAspirinPlatelet Aggregation InhibitorsProton Pump Inhibitors

Identifiers

PMID26978517
PMCPMC4792424
OpenAlexW2300951226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.